News | Information Technology | January 16, 2017

Stakeholders that are not invested in any of these by 2025 will fall behind the curve, finds Frost & Sullivan’s Transformational Health team

Frost & Sullivan, 18 technologies, growth opportunities, global healthcare, information technology, 2025

January 16, 2017 — Frost & Sullivan, released a new report, “Vision 2025 – Future of Healthcare,” part of the company’s Advanced Medical Technologies, that identifies 18 technologies that will impact healthcare paradigms by 2025.

Technology-driven transformation in global healthcare demands that stakeholders identify influential technologies and re-strategize to ride the strongest growth currents. As healthcare moves to the anytime, anyplace, continuous and personalized care model, technological advances are unlocking values and previously inaccessible segments.

“Although these technologies are making waves within research, two aspects must be weighed to assess potential market impact,” noted Frost & Sullivan Transformational Health Research Analyst Siddharth Shah. “The first is the commercialization and maturity timelines for these technologies. The second is aligning the technologies with Healthcare 2025 trends and themes in order to successfully leverage growth opportunities.”

Some technologies set to create billion-dollar opportunities, according to the report, include: wearables, enhanced prosthetics, nanorobotics, electroceuticals, advanced materials, population health analytics, quantum computing, wellness gamification, regenerative medicine and precision medicine.

To be profitable, companies must identify the technologies that will impact their business and invest accordingly, according to Frost & Sullivan. For instance:

  • Artificial intelligence (AI) is set to speed up the analysis of large volumes of data to efficiency levels that exceed human capability;
  • Brain-computer interfaces can connect a “wired” brain directly with an external device for “neural bypass,” which will help paralyzed patients move or blind patients see;
  • Digital avatars offer holographic projections of doctors to answer health queries, similar to voice assistants like Cortana and Siri; and
  • Medical tricorders can record health vitals and parameters to diagnose a range of health conditions without a physician.

Frost & Sullivan’s analysis offers timeframes for commercialization and indicates when significant on-the-ground healthcare impact will be seen for each technology. Some of the frontrunners in the race for enabling healthcare technologies include IBM Watson Health with its AI for healthcare, Organovo for 3-D bioprinting, DeepStream VR for its virtual reality applications, and QualComm with its $10 million tricorderX inducement prize contest to develop medical tricorders.

For more information: www.frost.com


Related Content

News | ASTRO

May 17, 2024 — Registration opens today for the American Society for Radiation Oncology's (ASTRO) 66th Annual Meeting ...

Time May 17, 2024
arrow
News | Enterprise Imaging

May 16, 2024 — AGFA HealthCare announced that St. Vincent’s Private Hospital in Dublin, Ireland, has chosen to implement ...

Time May 16, 2024
arrow
News | Artificial Intelligence

May 16, 2024 — deepc, the globally recognized digital medicine pioneer and market leader behind the leading AI operating ...

Time May 16, 2024
arrow
Sponsored Content | Case Study | Enterprise Imaging

Having the most efficient clinical workflows with enhanced diagnostic capabilities is a major goal for clinicians and ...

Time May 16, 2024
arrow
News | Enterprise Imaging

May 15, 2024 — etherFAX announced the expansion of its partnership with Hyland, a leading global provider of intelligent ...

Time May 15, 2024
arrow
News | Cybersecurity

May 13, 2024 — In the wake of the cybersecurity breach targeting the prominent healthcare system Ascension, a new study ...

Time May 13, 2024
arrow
News | Radiology Imaging

May 13, 2024 — National Basketball Association (NBA), the National Basketball Players Association (NBPA), and the Next ...

Time May 13, 2024
arrow
News | Radiation Oncology

May 10, 2024 — Mariana Oncology, a fully integrated biotechnology company pioneering a new era of radiopharmaceutical ...

Time May 10, 2024
arrow
News | ARRS

May 8, 2024 — Compared to males, women in radiology are at a consistently higher risk of not matching into diagnostic ...

Time May 08, 2024
arrow
News | Contrast Media

May 8, 2024 — Swedish biotech company Ascelia Pharma AB has announced that its liver imaging drug candidate, Orviglance ...

Time May 08, 2024
arrow
Subscribe Now